tiprankstipranks
Trending News
More News >
Eloxx Pharmaceuticals Inc (ELOX)
OTHER OTC:ELOX

Eloxx Pharmaceuticals (ELOX) Stock Statistics & Valuation Metrics

Compare
286 Followers

Total Valuation

Eloxx Pharmaceuticals has a market cap or net worth of $314.00. The enterprise value is -$1.88M.
Market Cap$314.00
Enterprise Value-$1.88M

Share Statistics

Eloxx Pharmaceuticals has 3,143,390 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,143,390
Owned by Insiders
Owned by Institutions

Financial Efficiency

Eloxx Pharmaceuticals’s return on equity (ROE) is 3.38 and return on invested capital (ROIC) is -1263.55%.
Return on Equity (ROE)3.38
Return on Assets (ROA)-1.71
Return on Invested Capital (ROIC)-1263.55%
Return on Capital Employed (ROCE)17.49
Revenue Per Employee0.00
Profits Per Employee-2.00M
Employee Count18
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Eloxx Pharmaceuticals is -0.11. Eloxx Pharmaceuticals’s PEG ratio is <0.01.
PE Ratio-0.11
PS Ratio0.00
PB Ratio-0.37
Price to Fair Value-0.37
Price to FCF-0.12
Price to Operating Cash Flow-0.12
PEG Ratio<0.01

Income Statement

In the last 12 months, Eloxx Pharmaceuticals had revenue of 0.00 and earned -36.06M in profits. Earnings per share was -16.65.
Revenue0.00
Gross Profit0.00
Operating Income-34.42M
Pretax Income-36.06M
Net Income-36.06M
EBITDA-33.37M
Earnings Per Share (EPS)-16.65

Cash Flow

In the last 12 months, operating cash flow was -17.99M and capital expenditures 0.00, giving a free cash flow of -17.99M billion.
Operating Cash Flow-17.99M
Free Cash Flow-17.99M
Free Cash Flow per Share-5.72

Dividends & Yields

Eloxx Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-1481.73
52-Week Price Change-2.60%
50-Day Moving Average
200-Day Moving Average
Relative Strength Index (RSI)
Average Volume (3m)863.00

Important Dates

Eloxx Pharmaceuticals upcoming earnings date is Nov 7, 2024, TBA (Confirmed).
Last Earnings DateAug 7, 2024
Next Earnings DateNov 7, 2024
Ex-Dividend Date

Financial Position

Eloxx Pharmaceuticals as a current ratio of 0.87, with Debt / Equity ratio of -125.55%
Current Ratio0.87
Quick Ratio0.87
Debt to Market Cap3.18
Net Debt to EBITDA0.17
Interest Coverage Ratio-17.66

Taxes

In the past 12 months, Eloxx Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Eloxx Pharmaceuticals EV to EBITDA ratio is 0.06, with an EV/FCF ratio of 0.06.
EV to Sales0.00
EV to EBITDA0.06
EV to Free Cash Flow0.06
EV to Operating Cash Flow0.06

Balance Sheet

Eloxx Pharmaceuticals has $4.78M in cash and marketable securities with $5.76M in debt, giving a net cash position of $983.00K billion.
Cash & Marketable Securities$4.78M
Total Debt$5.76M
Net Cash$983.00K
Net Cash Per Share$0.31
Tangible Book Value Per Share-$4.92

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Eloxx Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis